Angelo Michael Ninivaggi, Jr. Sells 3,113 Shares of Plexus Corp. (NASDAQ:PLXS) Stock

Plexus Corp. (NASDAQ:PLXS) CAO Angelo Michael Ninivaggi, Jr. sold 3,113 shares of the business’s stock in a transaction on Tuesday, October 29th. The stock was sold at an average price of $144.19, for a total value of $448,863.47. Following the completion of the transaction, the chief accounting officer now directly owns 35,323 shares of the company’s stock, valued at approximately $5,093,223.37. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Plexus Price Performance

PLXS opened at $147.01 on Friday. Plexus Corp. has a 1 year low of $90.18 and a 1 year high of $153.60. The company’s 50 day simple moving average is $132.42 and its 200 day simple moving average is $117.47. The stock has a market capitalization of $4.00 billion, a PE ratio of 36.66 and a beta of 0.89. The company has a debt-to-equity ratio of 0.07, a quick ratio of 0.71 and a current ratio of 1.51.

Plexus (NASDAQ:PLXS) last announced its quarterly earnings results on Wednesday, October 23rd. The technology company reported $1.85 earnings per share for the quarter, beating analysts’ consensus estimates of $1.55 by $0.30. The company had revenue of $1.05 billion for the quarter, compared to analyst estimates of $1.01 billion. Plexus had a net margin of 2.82% and a return on equity of 9.51%. Plexus’s revenue for the quarter was up 2.6% on a year-over-year basis. During the same quarter last year, the business earned $1.44 EPS. As a group, sell-side analysts expect that Plexus Corp. will post 6.2 EPS for the current year.

Wall Street Analyst Weigh In

PLXS has been the subject of several analyst reports. StockNews.com raised shares of Plexus from a “hold” rating to a “buy” rating in a research note on Tuesday. Benchmark boosted their price objective on shares of Plexus from $150.00 to $165.00 and gave the company a “buy” rating in a research report on Monday, October 28th. Needham & Company LLC raised their target price on shares of Plexus from $144.00 to $162.00 and gave the stock a “buy” rating in a research report on Friday, October 25th. Finally, KeyCorp started coverage on shares of Plexus in a research note on Tuesday, October 22nd. They issued a “sector weight” rating for the company. Three equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $133.50.

Institutional Investors Weigh In On Plexus

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Quest Partners LLC lifted its stake in shares of Plexus by 36,700.0% in the 2nd quarter. Quest Partners LLC now owns 368 shares of the technology company’s stock valued at $38,000 after purchasing an additional 367 shares in the last quarter. Farther Finance Advisors LLC lifted its position in Plexus by 89.4% during the third quarter. Farther Finance Advisors LLC now owns 464 shares of the technology company’s stock valued at $63,000 after buying an additional 219 shares in the last quarter. Innealta Capital LLC purchased a new stake in Plexus during the second quarter worth approximately $51,000. GAMMA Investing LLC increased its position in shares of Plexus by 190.1% in the third quarter. GAMMA Investing LLC now owns 760 shares of the technology company’s stock worth $104,000 after acquiring an additional 498 shares in the last quarter. Finally, EntryPoint Capital LLC raised its stake in shares of Plexus by 56.2% in the 1st quarter. EntryPoint Capital LLC now owns 976 shares of the technology company’s stock valued at $93,000 after acquiring an additional 351 shares during the period. 94.45% of the stock is currently owned by institutional investors and hedge funds.

Plexus Company Profile

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.